跳至主要内容
临床试验/ISRCTN13060768
ISRCTN13060768进行中(未招募)未知

Investigating organ complications in preeclampsia during and after pregnancy and the pregnant woman's and partner's health in the postpartum period: An observational cohort study involving the GO PROVE - Gothenburg Preeclampsia Obstetric Adverse Events and UPMOST - Uppsala Pregnancy Complication Study

Sahlgrenska University Hospital0 个研究点目标入组 300 人开始时间: 2020年7月27日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
300

研究概览

简要总结

2021 Protocol article in https://pubmed.ncbi.nlm.nih.gov/34819281/ (added 26/11/2021) 2023 Results article in https://pubmed.ncbi.nlm.nih.gov/37080010/ (added 17/08/2023)

研究设计

研究类型
Observational

入排标准

性别
Female

入选标准

  • Preeclampsia cohort:
  • 1. Primiparous and parous pregnant women
  • 2. Aged =18 years
  • 3. Diagnosis of preeclampsia after gestational week 20
  • Control cohort:
  • 1. Primiparous and parous women
  • 2. Aged =18 years
  • 3. Healthy pregnancies matched for gestational age

排除标准

  • Current participant exclusion criteria as of 10/01/2022:
  • 1. Unable to give written informed consent
  • 2. Magnetic resonance imaging (MRI) contraindications, including claustrophobia, for MR group only
  • 3. Diabetes Mellitus before or during pregnancy, pre-existing cardiovascular, renal, or cerebral disease, or pre-existing hypertension for special investigations including MRI, echocardiography, cerebral doppler measurements, and cognitive function assessment
  • Previous participant exclusion criteria:
  • 1. Unable to give written informed consent
  • 2. Pre-existing hypertension
  • 3. Diabetes Mellitus before or during pregnancy
  • 4. Pre-existing cardiovascular, renal, or cerebral disease
  • 5. Magnetic resonance imaging (MRI) contraindications, including claustrophobia, for MR group only

研究者

发起方
Sahlgrenska University Hospital

相似试验